📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19. (2021)

First Author: Kalil AC

Attributed to: Other infectious diseases of global public health significance funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1056/nejmoa2031994

PubMed Identifier: 33306283

Publication URI: http://europepmc.org/abstract/MED/33306283

Type: Journal Article/Review

Volume: 384

Parent Publication: The New England journal of medicine

Issue: 9

ISSN: 0028-4793